Scythian Biosciences Corp (SCYB.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,687 | 7,833 | 10,698 | 451 | 896 |
| Receivables | 2,908 | 773 | 301 | 246 | 583 |
| TOTAL | $9,082 | $9,274 | $11,973 | $711 | $1,492 |
| Non-Current Assets | |||||
| PPE Net | 351 | 352 | 388 | 424 | 461 |
| Investments And Advances | 2,363 | 4,135 | 884 | 749 | 765 |
| Intangibles | 6,197 | 6,887 | 6,891 | 56 | 60 |
| Other Non-Current Assets | 73 | 1,249 | 73 | 73 | 73 |
| TOTAL | $8,984 | $12,624 | $8,237 | $1,303 | $1,359 |
| Total Assets | $18,066 | $21,898 | $20,210 | $2,013 | $2,850 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 60 | 60 | 40 | 40 | 901 |
| TOTAL | $794 | $1,995 | $1,962 | $695 | $1,517 |
| Non-Current Liabilities | |||||
| Long Term Debt | 123 | 141 | 183 | 183 | 79 |
| TOTAL | $416 | $441 | $508 | $543 | $462 |
| Total Liabilities | $1,209 | $2,436 | $2,470 | $1,239 | $1,979 |
| Shareholders' Equity | |||||
| Common Shares | 44,913 | 45,837 | 45,139 | 23,440 | 21,963 |
| Retained earnings | -50,648 | -43,165 | -43,895 | -35,735 | -33,281 |
| Other shareholders' equity | 7,655 | 6,581 | 6,589 | 5,023 | 4,613 |
| TOTAL | $16,857 | $19,462 | $17,739 | $775 | $871 |
| Total Liabilities And Equity | $18,066 | $21,898 | $20,210 | $2,013 | $2,850 |